copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Erso Diagnostics Erso Diagnostics serves the medical community and related fields by providing rapid and reliable diagnostic insights that impact clinical decisions in clinical toxicology for medication monitoring and substance use testing
Welcome to ERSO | erso ERSO is a central administrative hub providing comprehensive research and administrative services to the College of Engineering, College of Environmental Design, Computing, Data Science Society, Mathematical Physical Sciences Division, School of Information, and various large research Institutes and Centers
Breast Cancer Tumors in Mice Eliminated by Single-Dose ErSO-TFPy A novel drug candidate developed by researchers at the University of Illinois called ErSO-TFPy, has demonstrated the ability to completely eliminate breast cancer tumors in mice with a single dose
A small-molecule activator of the unfolded protein response . . . - PubMed Seeking to target these drug-resistant cancers, we report the discovery of a compound, called ErSO, that activates the anticipatory unfolded protein response (a-UPR) and induces rapid and selective necrosis of ERα-positive breast cancer cell lines in vitro
Bayer and Systems Oncology sign exclusive license agreement for . . . ERSO is a small molecule activator of the Unfolded Protein Response (UPR) in ER-positive breast cancer cells ERSO’s mechanism of action is a therapeutic approach being investigated in women with metastatic ER-positive breast cancer, an area where new therapies are urgently required
One Shot Wonder: New Drug Eliminates Large Breast Tumors with Single . . . The new compound, called ErSO-TFPy, completely eliminated small breast tumors and dramatically shrank even large tumors after a single treatment – an achievement almost unheard of in cancer therapy Current treatments typically require daily medications for 5-10 years following surgery
CCIL Scientists’ Single Dose Breast Cancer Treatment Induces Complete . . . Experiments so far suggest that ErSO-TFPy is safe and potent enough for single dose efficacy, possibly eliminating the need for chronic treatment In addition to this impressive fact, the drug is also incredibly powerful even against large, late-stage tumors in mice